Lab-grown beating heart cells identify potential drug to prevent COVID-19-related heart damage
Patients with underlying heart problems are more than four times as likely to die from COVID-19
Patients with underlying heart problems are more than four times as likely to die from COVID-19
Low-cost device lets consumers check themselves for multiple strains of SARS-CoV-2 at home
Researchers have cataloged for the first time
It is hoped this therapy will be a breakthrough for patients suffering from hereditary transthyretin (ATTR) amyloidosis
The fully automated CN-3000 and CN-6000 Systems bring mid- and high-volume coagulation testing to laboratories
Vaccine aims to combat numerous HIV strains, a key requirement of any vaccine to end the HIV/AIDs epidemic
Dr. Erik Tillman shares his virtual company’s quest to find an effective new life-changing treatment for non-alcoholic steatohepatitis
Nobel prize winning CRISPR technology to be applied in development of genetically engineered animal models
Leading clinical laboratory runs first-ever successful automation of a CRISPR test for high-throughput, using Sherlock’s SARS-CoV-2 process
Scientists at University of Warwick demonstrate that levels of a protein – TPD54 – affect movement of cells
Researchers found that longer dosing intervals led to higher antibody levels and a higher proportion of ‘helper’ T cells
Findings explain higher risk of heart attack in people with diabetes, even after treatment
The multiplex PCR test is capable of screening six SARS-CoV-2 variants including the Delta and Delta Plus variants attributable for a recent surge in global COVID-19 cases
Immune repertoire assays offer high detection rates of malignant clones, empowering researchers to better assess blood cancers
Study finds switches near GDF5 gene linked to knee osteoarthritis, hip dysplasia
Dr. Lique Coolen and Dr. Aleisha Moore, Kent State University, present their latest research into the mechanisms underlying spinal cord injury and neuroendocrine dysfunction
Discover the impact of the COVID-19 pandemic on a clinical research facility and the future of clinical trial recruitment
The authorization enables emergency use of Actemra/RoActemra for the treatment of COVID-19 in hospitalized adult and pediatric patients
LGC has been working with NHS Test and Trace to support the UK's response to the pandemic